logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Catherine Thiéblemont

APHP
H指数:100
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

更正：在大型B细胞淋巴瘤的高风险患者中，术前修改的淋巴细胞清除能否改善预后？

Bone Marrow Transplantation
IF5.2
2026-03-020
OAAI
Marta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Côme Bommier; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Roberta Di Blasi; Sophie Caillat-Zucman; Catherine Thieblemont
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

改良的淋巴细胞清除术在大型B细胞淋巴瘤的高风险患者中能否改善预后？

Bone Marrow Transplantation
IF5.2
2026-01-080
OAAI
Marta Canelo-Vilaseca; Mohamad Sabbah; Caterina Cristinelli; Bommier Côme; Pierre Sesques; Mikael Roussel; Pierre Bories; Vincent Allain; Amani Ouedrani; Ilenia De Bernardis; Agathe Vely; Pierre Stephan; Laetitia Vercellino; Fabienne Venet; Rémi Pescarmona; Roch Houot; François Vergez; Romain de Jorna; Isabelle Madelaine; Nathalie Parquet; Anne C. Brignier; Jérôme Larghero; Miryam Mebarki; Di Blasi Roberta; Sophie Caillat-Zucman; Catherine Thieblemont
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group

抗CD19 CAR-T细胞疗法失败后套细胞淋巴瘤患者的结局：Descar-T研究（Lysa集团）

Blood Advances
IF7.1
2025-10-030
OAAI
Marion Aymard; Morgane Cheminant; Roch Houot; Anne Cuozzo; Elodie Gat; Catherine Thieblemont; Laure Ricard; Louise Roulin; Krimo Bouabdallah; Violaine Safar; Stephanie Guidez; Amandine Fayard; Gabriel Brisou; Loic Ysebaert; Olivier Hermine; Benoît Tessoulin; Charles Herbaux; Steven Le Gouill; Clementine Sarkozy
PROs versus clinician-reported adverse events in a large clinical trial: findings from the Phase 3 POLARIX study

患者报告结果(PROs)与临床医生报告的不良事件在大型临床试验中的比较：来自III期POLARIX研究的结果

Blood
IF23.1
2025-09-290
OA
Carrie Thompson; Marek Trněný; Franck Morschhauser; Gilles Salles; Patrick M. Reagan; Mark Hertzberg; Huilai Zhang; Catherine Thieblemont; Bei Hu; Gustavo Fonseca; Won Seog Kim; Maurizio Martelli; Amitkumar Mehta; Avrita Singh; Mark Yan; Jamie Hirata; Matthew Sugidono; Calvin Lee; Jeff P. Sharman; Neha Mehta-Shah; Christopher R. Flowers; Hervé Tilly; Neil Chua; René-Olivier Casasnovas; Fiona Miall; Tae Min Kim; Xavier Cheng-Hong Tsai; Sunita Nasta; Seung Tae Lee; Jonathan W. Friedberg
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up

弥漫大B细胞淋巴瘤（LBCL）：EHA 诊断、治疗和随访临床实践指南

HemaSphere
IF14.6
2025-09-230
OAAI
Catherine Thieblemont; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Natacha Bolanos; Maja Marković; Jean-Philippe Jais; Florence Broussais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Marie-José Kersten
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe

弥合欧洲大B细胞淋巴瘤疗法在临床试验可及性和报销方面的差距

HemaSphere
IF14.6
2025-09-230
OAAI
Florence Broussais; Elise Pennings; Natacha Bolanos; Lorna Warwick; Robin Doeswijk; Gauthier Quinonez; Andrii Lebeda; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Jean-Philippe Jais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Catherine Thieblemont; Marie Jose Kersten
Routine Prophylaxis with Levetiracetam offers no benefit in CD19 CAR-T for LBCL: a Multicenter Propensity-matched Study

常规使用左乙拉西坦进行预防对LBCL的CD19 CAR-T治疗无益：一项多中心倾向性匹配研究

Blood Advances
IF7.1
2025-08-110
OAAI
Eugenio Galli; Roberta Di Blasi; Alice Di Rocco; Caterina Cristinelli; Ilaria Pansini; Côme Bommier; Alessandro Corrente; Ilenia De Bernardis; Marcello Viscovo; Stefan Hohaus; Anna Modoni; Federica Sorà; Patrizia Chiusolo; Maurizio Martelli; Simona Sica; Catherine Thieblemont
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study

Brentuximab Vedotin联合Gemcitabine治疗复发或难治性外周T细胞淋巴瘤：一项LYSA II期研究

Blood Advances
IF7.1
2025-08-060
OAAI
Olivier Tournilhac; Kamal Bouabdallah; Solene Lecolant; Maya Hacini; Kamel Laribi; Sébastien Bailly; Thibaut Belmondo; Marie Maerevoet; Loic Ysebaert; Stephanie Guidez; Steven Le Gouill; Christophe Bonnet; Marc André; Jehan Dupuis; Catherine Thieblemont; Emmanuel Bachy; Nicolas Daguindau; Franck Morschhauser; Sabine Tricot; Charline Moulin; Anne Banos; Roch Houot; Adrien Chauchet; Emmanuel Gyan; Guillaume Cartron; Hassan Farhat; Vincent Camus; Bernard Drenou; Hacene Zerazhi; David Sibon; Emmanuelle Nicolas-Virelizier; Caroline Delette; Sylvia Snauwaert; Sarah Bailly; Richard Delarue; Sylvain Carras; Albane Ledoux-Pilon; Marie Parrens; Samuel Griolet; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Gandhi Laurent Damaj
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition

CAR T细胞治疗原发性或继发性中枢神经系统淋巴瘤患者的疗效和安全性: 代表EBMT和GoCART联盟的研究

HEMASPHERE
IF14.6
2025-05-210
OA
Saidy, Anna Ossami; Peczynski, Christophe; Thieblemont, Catherine; Daskalakis, Michael; Wehrli, Marc; Beauvais, David; Finke, Juergen; Schorb, Elisabeth; Vandenberghe, Peter; Berning, Philipp; Stelljes, Matthias; Ayuk, Francis; Ram, Ron; Von Bonin, Malte; Dreger, Peter; Bethge, Wolfgang; Kuhnl, Andrea; Jost, Lasse; Stoelzel, Friedrich; von Tresckow, Bastian; Renner, Christoph; Fuhrmann, Stephan; Galimard, Jacques-Emmanuelle; Michel, Eva; Bazarbachi, Ali; Balari, Anna Sureda; Schmitz, Norbert; Glass, Bertram
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

TRANSCAR：CD19 CAR T细胞疗法在复发/难治性转化型惰性淋巴瘤中的真实世界疗效

Blood Advances
IF7.1
2025-05-050
OAAI
Pierre Stephan; Roberta Di Blasi; Louise Roulin; Jean Galtier; Julien Calvani; Véronique Meignin; Marie Donzel; Alexandra Traverse-Glehen; Elsa Poullot; Marie Parrens; Vivien Dupont; Alexandra Marquet; Steven Le Gouill; Roch Houot; Francois-Xavier Gros; François Lemonnier; Emmanuel Bachy; Catherine Thieblemont; Pierre Sesques
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma

新型溴结构域和-extra-terminal结构域抑制剂BI 894999在晚期实体瘤或弥漫性大B细胞淋巴瘤患者中的Ia/Ib期研究最终结果

ESMO OPEN
IF8.3
2025-05-010
PRE
Lauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schoffski, P.
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study

Glofitamab在难治性或复发性弥漫性大B细胞淋巴瘤中的应用：一项在CAR-T细胞疗法失败后的II期LYSA研究

NATURE CANCER
IF28.5
2025-04-030
PRE
Cartron, Guillaume; Houot, Roch; Al Tabaa, Yassine; Le Bras, Fabien; Ysebaert, Loic; Choquet, Sylvain; Jardin, Fabrice; Bay, Jacques-Olivier; Gros, Francois-Xavier; Morschhauser, Franck; Casasnovas, Olivier; Gastinne, Thomas; Thieblemont, Catherine; Joris, Magalie; Ricard, Laure; Regny, Caroline; La Rochelle, Laurianne Drieu; Feugier, Pierre; Marcais, Ambroise; Griolet, Samuel; Laurent, Camille; Sesques, Pierre
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (vol 109, pg 2297, 2024)

苯达莫司汀和利妥昔单抗作为症状性脾 marginal zone 淋巴瘤的一线治疗：长期结局及早期不可测量微小残留病获得的影响——来自 BRISMA/IELSG36 期 II 研究的数据（vol 109, pg 2297, 2024）

HAEMATOLOGICA
IF7.9
2025-04-010
OA
Iannitto, Emilio; Ferrero, Simone; Bommier, Come; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

塔泽莫斯托stat与R-CHOP联合治疗新诊断弥漫性大B细胞淋巴瘤老年患者的疗效：LYSA的EpiRCHOP II期研究结果

ECLINICALMEDICINE
IF10
2025-04-010
PRE
Sarkozy, Clementine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cedric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stephanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent

研究方向

暂未获取到该数据
O
Olivier Casasnovas
H 指数:86论文数:635被引数:2.4万
F
Franck Morschhauser
H 指数:92论文数:929被引数:3.3万
G
Gilles Salles
H 指数:129论文数:1,725被引数:7.8万
C
Corinne Haïoun
H 指数:103论文数:781被引数:3.7万
S
Steven Le Gouill
H 指数:69论文数:705被引数:1.8万
R
Roch Houot
H 指数:60论文数:497被引数:1.3万
R
Roberta Di Blasi
H 指数:29论文数:130被引数:4,304
H
Hervé Tilly
H 指数:102论文数:807被引数:4.4万
O
Olivier Hermine
H 指数:135论文数:1,809被引数:6.4万
E
Emmanuel Bachy
H 指数:48论文数:534被引数:1.0万